FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

8089211000001106: Irinotecan 40mg/2ml solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22914101000001118 Irinotecan 40mg/2ml solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52433101000001116 Irinotecan 40mg/2ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 40mg/2ml solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Is pack of Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has active ingredient Irinotecan false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has VMP Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has VMP Irinotecan 40mg/2ml solution for infusion vials false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has VMP Irinotecan 40mg/2ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Campto 40mg/2ml solution for injection vials (Pfizer Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial Is a True Irinotecan 40mg/2ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start